CHRONIC KIDNEY DISEASE STAGE3
Clinical trials for CHRONIC KIDNEY DISEASE STAGE3 explained in plain language.
Never miss a new study
Get alerted when new CHRONIC KIDNEY DISEASE STAGE3 trials appear
Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE STAGE3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Zapping kidney nerves to tame tough blood pressure
Disease control CompletedThis study tested a device that uses ultrasound to calm overactive nerves in the kidneys, which can drive up blood pressure. It included 44 people with chronic kidney disease stage 3 whose blood pressure remained high despite taking multiple medications. Half received the real pr…
Matched conditions: CHRONIC KIDNEY DISEASE STAGE3
Phase: NA • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
At-Home kidney care: new study lets diabetes patients test drugs without leaving the house
Disease control CompletedThis study tested whether people with type 2 diabetes and kidney damage can safely participate in a clinical trial from home. Twelve participants took the drug empagliflozin, and depending on their response, some added or switched to finerenone. The goal was to see if remote data…
Matched conditions: CHRONIC KIDNEY DISEASE STAGE3
Phase: PHASE4 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New drug gemini tested for kidney disease safety
Disease control CompletedThis early-stage study tested a single dose of the drug Gemini in 40 adults with stage 3 or 4 chronic kidney disease. The main goal was to check if Gemini is safe and tolerable compared to a placebo. Researchers also looked at how the drug moves through the body and its effects o…
Matched conditions: CHRONIC KIDNEY DISEASE STAGE3
Phase: PHASE1, PHASE2 • Sponsor: Revelation Biosciences, Inc • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC